| Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma MJ Hicks, K Funato, L Wang, E Aronowitz, JP Dyke, DJ Ballon, ... Cancer gene therapy 22 (1), 1-8, 2015 | 29 | 2015 |
| Anti-epidermal growth factor receptor gene therapy for glioblastoma MJ Hicks, MJ Chiuchiolo, D Ballon, JP Dyke, E Aronowitz, K Funato, ... PLoS One 11 (10), e0162978, 2016 | 26 | 2016 |
| Cocaine vaccine dAd5GNE protects against moderate daily and high-dose “binge” cocaine use DF Havlicek, JB Rosenberg, BP De, MJ Hicks, D Sondhi, SM Kaminsky, ... PloS one 15 (11), e0239780, 2020 | 22 | 2020 |
| Anti-phospho-tau gene therapy for chronic traumatic encephalopathy CB Sacramento, D Sondhi, JB Rosenberg, A Chen, S Giordano, E Pey, ... Human Gene Therapy 31 (1-2), 57-69, 2020 | 21 | 2020 |
| Translation of an Adenovirus-Based Cocaine Vaccine dAd5GNE to a Clinical Trial DF Havlicek, B De, J Rosenberg, O Pagovich, D Sondhi, S Kaminsky, ... Molecular Therapy 24, S16, 2016 | 5 | 2016 |
| A single closed head injury in male adult mice induces chronic, progressive white matter atrophy and increased phospho-tau expressing oligodendrocytes DF Havlicek, R Furhang, E Nikulina, B Smith-Salzberg, S Lawless, ... Experimental Neurology 359, 114241, 2023 | 4 | 2023 |
| Efficacy of the dAd5GNE Anti-Cocaine Vaccine in Models of" Binge" Cocaine Use DF Havlicek, MJ Hicks, BP De, JB Rosenberg, SM Kaminsky, KD Janda, ... MOLECULAR THERAPY 22, S302-S302, 2014 | 2 | 2014 |
| Adenovirus-Based Vaccines for the Treatment of Substance Use Disorders DF Havlicek, JB Rosenberg, D Sondhi, RG Crystal, SM Kaminsky Biologics to Treat Substance Use Disorders: Vaccines, Monoclonal Antibodies …, 2016 | 1 | 2016 |
| Safety of Vaccination to Treat Cocaine Addiction with Capsid Proteins from a Disrupted Adenovirus Conjugated to a Cocaine Analog DF Havlicek, L Beatty, L Quach, S Monette, BP De, JB Rosenberg, ... Molecular Therapy 23, S180-S181, 2015 | 1 | 2015 |
| Gene Delivery of APOE2 Reduces Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease L Zhao, AJ Gottesdiener, M Parmar, C Grevstad, D Havlicek, J Rosenberg, ... Molecular Therapy 23, S154, 2015 | 1 | 2015 |
| Chronic and progressive deficits after a single closed head injury in mice S Lawless, D Havlicek, C Kelley, E Nikulina, PJ Bergold | | 2021 |
| Chronic and progressive motor deficits and cerebral atrophy following a single traumatic brain injury in mice S Lawless, A Siefert, JF Crary, DF Havlicek, C Kelley, E Nikulina, ... Journal of Neurotrauma 38 (14), A105-A105, 2021 | | 2021 |
| AAV-Mediated Local Anti-EGFR Antibody Gene Expression in CNS Delays Tumor Growth and Increases Survival in a Human Glioblastoma Xenograft Model MJ Chiuchiolo, MJ Hicks, Y Xie, F Fan, JB Rosenberg, JP Dyke, K Funato, ... Molecular Therapy 23, S287, 2015 | | 2015 |
| AAV-Mediated CNS Gene Transfer of Bevacizumab Reduces Human Glioblastoma Growth and Increases Survival in Mice MJ Hicks, K Funato, L Wang, E Aronowitz, JP Dyke, DJ Ballon, VS Tabar, ... MOLECULAR THERAPY 21, S4-S5, 2013 | | 2013 |
| AAV-Mediated CNS Gene Transfer of Bevacizumab Reduces Glioblastoma Growth and Increases Survival in Mice MJ Hicks, L Wang, E Aronowitz, JP Dyke, DJ Ballon, K Funato, VS Tabar, ... MOLECULAR THERAPY 20, S131-S132, 2012 | | 2012 |
